# Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）

> **NCT05978089** · PHASE4 · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Coronary Syndrome

## Interventions

- **DRUG:** Yangxinshi tablet
- **DRUG:** Yangxinshi tablet simulants

## Key facts

- **NCT ID:** NCT05978089
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-08
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978089, "Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05978089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*